ENDRA Life Sciences Inc.

NasdaqCM:NDRA Stock Report

Market Cap: US$2.9m

ENDRA Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NDRA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders870.0162%
Institutions6,2551.17%
General Public530,56698.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 11013.8%.

Top Shareholders

Top 19 shareholders own 1.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.43%
Virtu Financial LLC, Asset Management Arm
2,300US$12.3k0%no data
0.13%
L1 Capital Pty. Limited
686US$3.7k0%no data
0.13%
Shamir Capital
686US$3.7k0%0.16%
0.1%
Two Sigma Securities, LLC, Asset Management Arm
548US$2.9k0%no data
0.087%
Tower Research Capital Europe Limited
466US$2.5k2,350%no data
0.075%
Two Sigma Investments, LP
404US$2.2k0%no data
0.074%
Hudson River Trading LLC, Asset Management Arm
395US$2.1k110%no data
0.06%
Jane Street Group, LLC, Asset Management Arm
320US$1.7k385%no data
0.054%
Jump Trading, LLC, Asset Management Arm
291US$1.6k0%no data
0.014%
Morgan Stanley, Investment Banking and Brokerage Investments
74US$396.21,380%no data
0.011%
Anthony DiGiandomenico
59US$316.00%no data
0.008%
Geode Capital Management, LLC
43US$230.30%no data
0.0041%
The Vanguard Group, Inc.
22US$117.90%no data
0.0037%
Michael Thornton
20US$107.30%no data
0.0035%
NewEdge Advisors, LLC
19US$101.811.8%no data
0.00093%
Alexander Tokman
5US$26.70%no data
0.00037%
Michael Harsh
2US$10.60%no data
0.00019%
Bank of America Corporation, Asset Management Arm
1US$5.50%no data
0.00019%
Louis Basenese
1US$5.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 23:25
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ENDRA Life Sciences Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Kyle BauserColliers Securities